CTRI/2023/06/054362尚未招募4 期
To compare effect of Inj ranibizumab0.25mg versus inj Aflibercept 1mg in Retinopathy of Prematurity. - Ranibizumab versus aflibercept in ROP
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Premature newborns of APROP (aggressive posterior rop) and Hybrid ROP which is presence of ridge tissue, characteristic of staged ROP along with flat neovascular syncytium, and character of APROP in same eye.
排除标准
- •Patients with stage 4 and stage 5 ROP
- •Patients with pre existing ocular disease like congenital cataract, congenital glaucoma and other retinopathy
研究者
相似试验
已完成
不适用
Comparison of inravitreal ranibizumab therapy with and without laser photocoagulation for diabetic macular edema.diabetic macular edemaJPRN-UMIN000024697Tokyo Women's Medical University100
招募中
2 期
A phase II, 12 month, randomized, sham-controlled trial of ranibizumab (Lucentis) combined with grid laser compared with laser alone for the treatment of recalcitrant, diabetic macular oedema.Diabetic Macular OedemaEye - Diseases / disorders of the eyeMetabolic and Endocrine - DiabetesDiabetic RetinopathyACTRN12611000063910ovartis40
已完成
不适用
Comparison of intravitreal ranibizumab injection with or without tissue plasminogen activator in the treatment of type 2 choroidal neovascularizationeovascular age-related macular degenerationJPRN-UMIN000017081Department of Ophthalmology and Visual Science Nagoya City University Graduate School of Medical Sciences20
进行中（未招募）
不适用
Comparision of Ranibizumab (Lucentis) Monotherapy versus Combination of Ranibizumab (Lucentis) with Photodynamic Therapy (Verteporfin) in Patients with Subfoveal Choroidal Neovascularisation due to Age-Related Macular Degeneration - KAV-RanibizumabEUCTR2006-006760-28-ATudwig Boltzmann Institut für Retinologie und biomikroskopische Laserchirurgie45
招募中
2 期
A phase 2, twelve month, randomized, controlled trial of combined treatment for exudative age related macular degeneration with variable dosing Ranibizumab (Lucentis) and Sub-Tenon Triamcinolone (Kenacort-A 40).exudative age related macular degenerationEye - Diseases / disorders of the eyeACTRN12611000091909Royal Adelaide Hospital40